US biotech firm wants to test its pneumonia treatment in COVID-19 patients
A New Jersey biotech firm believes its drug could help save the lives of the sickest coronavirus patients. BioAegis Therapeutics has been testing a protein called gelsolin to treat pneumonia. Gelsolin exists naturally in the human body and helps to combat inflammation like that seen in critically ill and dying coronavirus patients. In early stages, … Read more